We are live on ! Find out more
SFE

Safeguard Scientifics, Inc.

Delisted

SFE was delisted on the 9th of February, 2024.

70 hedge funds and large institutions have $103M invested in Safeguard Scientifics, Inc. in 2021 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 13 increasing their positions, 34 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

76% more call options, than puts

Call options by funds: $656K | Put options by funds: $373K

12% more capital invested

Capital invested by funds: $91.8M → $103M (+$11.2M)

0% more funds holding in top 10

Funds holding in top 10: 55 (0)

8% less funds holding

Funds holding: 7670 (-6)

46% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 13

62% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 34

Holders
70
Holders Change
-6
Holders Change %
-7.89%
% of All Funds
1.23%
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.09%
New
7
Increased
13
Reduced
34
Closed
13
Calls
$656K
Puts
$373K
Net Calls
+$283K
Net Calls Change
+$967K
Name Holding Trade Value Shares
Change
Change in
Stake
YCM
1
Yakira Capital Management
Connecticut
$9.44M -$48K -6,000 -0.6%
Vanguard Group
2
Vanguard Group
Pennsylvania
$9.03M +$327K +40,829 +4%
First Manhattan
3
First Manhattan
New York
$8.71M -$401K -50,111 -5%
MAP
4
Madison Avenue Partners
New York
$8.57M +$2.53M +316,209 +49%
NRC
5
North Run Capital
Massachusetts
$7.96M +$403K +50,286 +6%
CCM
6
Contrarian Capital Management
Connecticut
$6.22M +$5.37M +670,561 +2,210%
ZIG
7
Zuckerman Investment Group
Illinois
$5.65M -$170K -21,203 -3%
BlackRock
8
BlackRock
New York
$5.17M +$22.1K +2,756 +0.5%
CM
9
CM Management
Florida
$5.11M
SCM
10
Solas Capital Management
Connecticut
$4.67M -$2.59M -323,649 -38%
Dimensional Fund Advisors
11
Dimensional Fund Advisors
Texas
$4.22M -$845K -105,560 -18%
CP
12
Clayton Partners
California
$3.94M -$3.3M -411,998 -48%
Walleye Trading
13
Walleye Trading
New York
$2.18M +$1.97M +245,814 New
ZCA
14
Zeke Capital Advisors
Pennsylvania
$1.81M
Janus Henderson Group
15
Janus Henderson Group
United Kingdom
$1.7M
Geode Capital Management
16
Geode Capital Management
Massachusetts
$1.6M +$23.8K +2,974 +2%
HCM
17
Horton Capital Management
Pennsylvania
$1.57M -$2.44M -304,722 -63%
Arrowstreet Capital
18
Arrowstreet Capital
Massachusetts
$1.57M -$88.3K -11,024 -6%
Renaissance Technologies
19
Renaissance Technologies
New York
$1.43M -$476K -59,500 -27%
Legal & General Group
20
Legal & General Group
United Kingdom
$1.14M -$40.5K -5,055 -4%
Two Sigma Advisers
21
Two Sigma Advisers
New York
$1.05M +$573K +71,500 +151%
Citadel Advisors
22
Citadel Advisors
Florida
$896K +$154K +19,222 +24%
ERSOT
23
Employees Retirement System of Texas
Texas
$888K +$801K +100,000 New
EC
24
EJF Capital
Virginia
$799K +$721K +90,000 New
E
25
Ergoteles
New York
$766K +$10.2K +1,274 +1%

SFE Hedge Fund Activity: Q3 2021 in Review

70 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Safeguard Scientifics, Inc. (SFE) for Q3 2021, worth a combined $103M — up 12% from $91.8M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of SFE and 7 opened new positions — a net loss of 6 holders — while 34 trimmed existing stakes and 13 added.

The largest buyer was Contrarian Capital Management, adding an estimated $5.37M. The largest seller was Clayton Partners, cutting an estimated $3.3M.

  • 70 institutional investors held Safeguard Scientifics, Inc. (SFE) as of Q3 2021, down from 76 in Q2 2021.
  • Funds reported $103M of Safeguard Scientifics, Inc. stock for Q3 2021, up 12% quarter-over-quarter.
  • 7 funds opened new Safeguard Scientifics, Inc. positions in Q3 2021 and 13 closed out, a net change of -6 holders.
  • The largest Safeguard Scientifics, Inc. buyer in Q3 2021 was Contrarian Capital Management, an estimated $5.37M added.
  • The largest Safeguard Scientifics, Inc. seller in Q3 2021 was Clayton Partners, an estimated $3.3M sold.

Based on aggregated 13F filings for Q3 2021.